Eye Surgery Meets Robotics

Published by www.calcalistech.com on June 24, 2025.

Israeli eye surgery robotics company ForSight Robotics has raised $125 million in a Series B round led by Eclipse. The funding will be used to advance development of the company’s ORYOM platform, a robotic system designed to perform cataract surgery and treat other common eye diseases. The system aims to deliver more precise procedures, expand access to quality care, and reduce the physical burden on surgeons. ForSight’s first human clinical trials are expected to begin this year.

Founded in 2020 by Prof. Moshe Shoham, Dr. Daniel Glozman, and Dr. Joseph Nathan, ForSight is currently headquartered in Yokneam Illit and will soon relocate to Caesarea. The company has raised $195 million to date and employs 110 people in Israel.

In addition to Eclipse, the round included investment from a strategic corporate partner, Dr. Fred Moll, who is widely regarded as the “father of surgical robotics,” India’s Adani Group, Reiya Ventures, and other existing backers. The company has already conducted hundreds of successful preclinical procedures in animal trials and will soon begin robotic cataract surgeries in humans.

“We finalized the round while missiles were flying into Israel. Twenty percent of our team is in the reserves, we support them and their families deeply,” Natahn told Calcalist. “We’ve faced COVID, economic crises, and now war. Still, we secured backing from some of Silicon Valley’s largest funds in both our Series A and B. Our uniqueness is stronger than the challenges around us.”

Dr. Nathan emphasized that the round represents a strong vote of confidence from a key industry player “A strategic company in our space invested a substantial amount, but entered only as a financial partner, I’m not tied to them strategically. All funds go to the company and are not contingent on milestones.”

Keep reading at calcalistech.com.

ForSight Robotics was co-founded in 2020 by Technion Professor Emeritus Moshe Shoham, Dr. Daniel Glozman, and Technion alumnus Dr. Joseph Nathan, who holds the positions of president and chief medical officer.

More Health & Medicine stories